Paul Karpecki

4.7k total citations · 1 hit paper
68 papers, 2.9k citations indexed

About

Paul Karpecki is a scholar working on Public Health, Environmental and Occupational Health, Ophthalmology and Dermatology. According to data from OpenAlex, Paul Karpecki has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Public Health, Environmental and Occupational Health, 33 papers in Ophthalmology and 21 papers in Dermatology. Recurrent topics in Paul Karpecki's work include Ocular Surface and Contact Lens (53 papers), Glaucoma and retinal disorders (24 papers) and Allergic Rhinitis and Sensitization (18 papers). Paul Karpecki is often cited by papers focused on Ocular Surface and Contact Lens (53 papers), Glaucoma and retinal disorders (24 papers) and Allergic Rhinitis and Sensitization (18 papers). Paul Karpecki collaborates with scholars based in United States, United Kingdom and Switzerland. Paul Karpecki's co-authors include Lyndon Jones, Preeya K. Gupta, Kathy Dumbleton, James S. Wolffsohn, Louis Tong, Sihem Lazreg, Benjamin D. Sullivan, Alan Tomlinson, Jennifer P. Craig and Reiko Arita and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Paul Karpecki

60 papers receiving 2.8k citations

Hit Papers

TFOS DEWS II Diagnostic Methodology report 2017 2026 2020 2023 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TFOS DEWS II Diagnostic Methodology report
    2017 1.5k citations James S. Wolffsohn, Reiko Arita et al. The Ocular Surface profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Karpecki United States 23 2.4k 1.2k 868 843 763 68 2.9k
Mônica Alves Brazil 22 2.7k 1.1× 1.3k 1.0× 996 1.1× 766 0.9× 591 0.8× 73 3.2k
Florence Malet France 22 2.6k 1.1× 1.9k 1.6× 2.2k 2.5× 642 0.8× 453 0.6× 58 3.9k
Joon Young Hyon South Korea 29 1.1k 0.5× 929 0.8× 882 1.0× 289 0.3× 311 0.4× 147 2.3k
Richard Yudi Hida Brazil 12 1.2k 0.5× 578 0.5× 549 0.6× 311 0.4× 345 0.5× 39 1.5k
Vicki Evans Australia 11 1.4k 0.6× 789 0.7× 608 0.7× 217 0.3× 248 0.3× 24 1.6k
Won Choi South Korea 19 721 0.3× 344 0.3× 368 0.4× 131 0.2× 133 0.2× 51 1.1k
Fabian Garreis Germany 24 674 0.3× 301 0.3× 348 0.4× 95 0.1× 94 0.1× 66 1.4k
Natalie A. Afshari United States 34 894 0.4× 2.1k 1.7× 2.1k 2.5× 72 0.1× 117 0.2× 144 3.5k
Aparna Raychaudhuri United States 15 451 0.2× 143 0.1× 115 0.1× 219 0.3× 160 0.2× 31 1.3k
Seth P. Epstein United States 14 425 0.2× 477 0.4× 321 0.4× 81 0.1× 83 0.1× 21 1.1k

Countries citing papers authored by Paul Karpecki

Since Specialization
Citations

This map shows the geographic impact of Paul Karpecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Karpecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Karpecki more than expected).

Fields of papers citing papers by Paul Karpecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Karpecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Karpecki. The network helps show where Paul Karpecki may publish in the future.

Co-authorship network of co-authors of Paul Karpecki

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Karpecki. A scholar is included among the top collaborators of Paul Karpecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Karpecki. Paul Karpecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arbuckle, Rob, et al.. (2025). Psychometric validation of the Chronic Ocular Pain Questionnaire (COP-Q). Journal of Patient-Reported Outcomes. 9(1). 32–32.
2.
Davey, Pinakin Gunvant, Marjan Farid, Paul Karpecki, et al.. (2024). Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis. Healthcare. 12(15). 1487–1487. 3 indexed citations
3.
Barnett, Melissa, William E. Whitson, Gregg J. Berdy, et al.. (2024). The impact of Demodex blepharitis on patient symptoms and daily life. Optometry and Vision Science. 101(3). 151–156. 5 indexed citations
4.
Holland, Edward J., Paul Karpecki, Murray Fingeret, et al.. (2024). Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials. Clinical Therapeutics. 46(2). 104–113. 5 indexed citations
5.
Karpecki, Paul, et al.. (2024). Qualitative Research to Understand the Patient Experience and Evaluate Content Validity of the Chronic Ocular Pain Questionnaire (COP-Q). Ophthalmology and Therapy. 13(2). 615–633. 3 indexed citations
6.
7.
Karpecki, Paul & John D. Sheppard. (2023). Perfluorohexyloctane ophthalmic solution: a review of a prescription treatment for dry eye disease that directly targets tear evaporation. Expert Review of Ophthalmology. 18(6). 355–364.
8.
Kaiser, Peter K., Paul Karpecki, Carl D. Regillo, et al.. (2023). Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment. BMJ Open Ophthalmology. 8(1). e001395–e001395. 6 indexed citations
9.
Rhee, Michelle K., Elizabeth Yeu, Melissa Barnett, et al.. (2023). Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies. Eye & Contact Lens Science & Clinical Practice. 49(8). 311–318. 32 indexed citations
10.
Sheppard, John D., Paul Karpecki, Michael B. Raizman, et al.. (2023). Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?. Optometry and Vision Science. 100(2). 164–169. 7 indexed citations
11.
Farid, Marjan, Brandon D. Ayres, Eric D. Donnenfeld, et al.. (2023). Delphi Panel Consensus Regarding Current Clinical Practice Management Options for Demodex blepharitis. Clinical ophthalmology. Volume 17. 667–679. 9 indexed citations
12.
Clark, David L., Paul Karpecki, Anne Marie Salapatek, John D. Sheppard, & Todd C. Brady. (2022). Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure. SHILAP Revista de lepidopterología. 11 indexed citations
13.
Nichols, Kelly K., et al.. (2022). Topical Review: An Update of Diagnostic and Management Algorithms for Acquired Blepharoptosis. Optometry and Vision Science. 99(3). 230–240. 1 indexed citations
14.
Karpecki, Paul, Charles B. Slonim, Konstantinos Charizanis, et al.. (2021). Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial. Optometry and Vision Science. 98(3). 234–242. 4 indexed citations
15.
Smyth-Medina, Robert, Barry A. Schechter, Bridgitte Shen Lee, et al.. (2019). Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. Journal of Ocular Pharmacology and Therapeutics. 35(7). 388–394. 12 indexed citations
16.
Holland, Edward J., Mahshad Darvish-Zargar, Kelly K. Nichols, Lyndon Jones, & Paul Karpecki. (2019). Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review. The Ocular Surface. 17(3). 412–423. 61 indexed citations
17.
Wolffsohn, James S., Reiko Arita, Robin L. Chalmers, et al.. (2017). TFOS DEWS II Diagnostic Methodology report. The Ocular Surface. 15(3). 539–574. 1463 indexed citations breakdown →
18.
Karpecki, Paul. (2015). Kanski’s Clinical Ophthalmology. Optometry and Vision Science. 92(10). e386–e386. 44 indexed citations
19.
Comstock, Timothy L., Paul Karpecki, Timothy W. Morris, & et al. (2010). Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis. SHILAP Revista de lepidopterología. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mônica Alves Breakdown of academic impact, for papers by Florence Malet Breakdown of academic impact, for papers by Joon Young Hyon Breakdown of academic impact, for papers by Richard Yudi Hida Breakdown of academic impact, for papers by Vicki Evans Breakdown of academic impact, for papers by Won Choi Breakdown of academic impact, for papers by Fabian Garreis Breakdown of academic impact, for papers by Natalie A. Afshari Breakdown of academic impact, for papers by Aparna Raychaudhuri Breakdown of academic impact, for papers by Seth P. Epstein
Rankless by CCL
2026